Diffuse large B-cell lymphoma in very elderly patients: Towards best tailored treatment – A systematic review-Reference-Cited by-同舟云学术

Diffuse large B-cell lymphoma in very elderly patients: Towards best tailored treatment – A systematic review

Published:2021-04 Issue: Volume:160 Page:103294
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Tavares Alda^ORCID,Moreira Ilídia^ORCID

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference55 articles.

1. Efficacy and tolerability of reduced-dose 21-day cycle rituximab and cyclophosphamide, doxorubicin, vincristine and prednisolone therapy for elderly patients with diffuse large B-cell lymphoma;Aoki;Leuk. Lymphoma,2013

2. Comparison of R-CVP with R-CHOP for very elderly patients aged 80 or over with diffuse large B cell lymphoma;Arakaki;Ann. Hematol.,2017

3. A real-world study of first-line therapy in 280 consecutive Swedish patients ≥80 years with newly diagnosed diffuse large B-cell lymphoma: very elderly (≥85 years) do well on curative intended therapy;Asklid;Leuk. Lymphoma,2020

4. Comprehensive geriatric assessment (CGA): a simple tool for guiding the treatment of older adults with diffuse large B-Cell lymphoma in China;Bai;Oncologist,2020

5. Frontline treatment of diffuse large B-cell lymphoma in elderly: a systematic review of clinical trials in post-rituximab era;Beygi;Leuk. Lymphoma,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the cancer aging and research group model in predicting immunochemotherapy toxicity among elderly patients with diffuse large B-cell lymphoma;International Immunopharmacology;2024-09

2. Predictors of Survival, Treatment Modalities, and Clinical Outcomes of Diffuse Large B-Cell Lymphoma in Patients Older Than 70 Years Still an Unmet Medical Need in 2024 Based on Real-World Evidence;Cancers;2024-04-11

3. Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma;Journal of Clinical and Experimental Hematopathology;2023-12-26

4. Comprehensive geriatric assessment and clinical outcomes of frail older adults with diffuse large B-cell lymphoma: a meta-analysis;Oncology in Clinical Practice;2023-12-19

5. Diffuse large B-cell lymphoma successfully treated with amplified natural killer therapy alone: A case report;World Journal of Clinical Cases;2023-10-26